Opus Genetics IRD Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance.
The official record: Opus Genetics’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent?
- Opus Genetics (IRD) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent of -9.3% in Q4 2025.
- How has Opus Genetics's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent changed year-over-year?
- Opus Genetics's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent increased by 64.9% year-over-year, from -26.5% to -9.3%.
- What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent mean?
- The percentage point impact on the effective tax rate attributable to changes in the valuation allowance for deferred tax assets. This metric quantifies how adjustments to tax asset recoverability influence the company's overall tax profile.